Variables | Frequency (n) | Percentage (%) |
---|---|---|
Duration between HIV test confirmed and enrollment | ||
< 6 months | 291 | 72.4 |
6–12 months | 46 | 11.4 |
> 12 months | 65 | 16.2 |
Any medication before ART initiation | ||
No | 299 | 74.4 |
Yes | 103 | 25.6 |
Past OI at enrollment | ||
No | 214 | 53.2 |
Yes | 188 | 46.8 |
Cotrimoxazole prophylaxis | ||
No | 42 | 10.4 |
Yes | 360 | 89.6 |
INH prophylaxis | ||
No | 338 | 84.1 |
Yes | 64 | 15.9 |
TB treatment history | ||
No | 336 | 83.6 |
Yes | 66 | 16.4 |
Chronic disease | ||
No | 324 | 80.6 |
Yes | 78 | 19.4 |
Immunization status | ||
Appropriate for age | 323 | 80.3 |
Not appropriate for age | 67 | 16.7 |
Not Immunized | 12 | 3 |
WHO stage at HIV test | ||
I | 136 | 33.8 |
II | 133 | 33.1 |
III | 98 | 24.4 |
IV | 35 | 8.7 |
Functional status (≥ 5 years) | ||
Working | 120 | 47.8 |
Ambulatory/bedridden | 131 | 52.2 |
Developmental milestone (< 5 years) | ||
Appropriate ranges for age | 116 | 76.8 |
Developmental delay/regression | 35 | 23.2 |
CD4 count (> 5 years) | ||
< 250 cells/mm3 | 50 | 20.2 |
≥ 250 cells/mm3 | 198 | 79.8 |
CD4 percentage (≤ 5 years) | ||
< 15% | 37 | 24.0 |
15–25% | 39 | 25.3 |
> 25% | 78 | 50.7 |
WHO stage at ART initiation | ||
I | 94 | 23.4 |
II | 136 | 33.8 |
III | 130 | 32.3 |
IV | 42 | 10.5 |
Year of ART initiation | ||
2007–2008 | 69 | 17.2 |
2009–2011 | 137 | 34.1 |
2012–2014 | 115 | 28.6 |
2015–2016 | 81 | 20.1 |